Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand
Sermsiri Sangroongruangsri,1 Usa Chaikledkaew,1,2 Prut Hanusaha,3 Tanapat Ratanapakorn,4 Paisan Ruamviboonsuk5 1Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand; 2Mahidol University Health Technology Assessment (MUHTA) Gr...
Saved in:
Main Authors: | Sangroongruangsri S (Author), Chaikledkaew U (Author), Hanusaha P (Author), Ratanapakorn T (Author), Ruamviboonsuk P (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy
by: Peng Y, et al.
Published: (2018) -
One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
by: Hsin-Yu Weng, et al.
Published: (2019) -
Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
by: Yinchen Shen, et al.
Published: (2022) -
Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy
by: Misa Kimura, et al.
Published: (2024) -
Avoiding errors in the diagnosis of polypoidal choroidal vasculopathy in patients with age-related macular degeneration (Part 1)
by: Lutsenko N. S., et al.
Published: (2021)